Tg(TcraB16.3,TcrbB16.3)AMcd
Transgene Detail
|
|
| Symbol: |
Tg(TcraB16.3,TcrbB16.3)AMcd |
| Name: |
transgene insertion A, Hugh O McDevitt |
| MGI ID: |
MGI:5909255 |
| Synonyms: |
B16.3, Valpha4.5-Jalpha6 and Vbeta1-Jbeta2.7 |
| Transgene: |
Tg(TcraB16.3,TcrbB16.3)AMcd Location: unknown
|
| Alliance: |
Tg(TcraB16.3,TcrbB16.3)AMcd page
|
|
|
|
| Transgene Type: |
|
Transgenic (Inserted expressed sequence) |
| Mutation: |
|
Insertion
|
| |
|
Mutation details: The transgene contains the prearranged Tcr recognizing the peptide epitope 286-300 (p286) of GAD2 (p286) from the hydridoma cell line B16.3 (Valpha4.5-Jalpha6 and Vbeta1-Jbeta2.7). Lines A and B were generated with line A selected the representative line.
(J:78642)
|
|
|
| Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
| Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
|
| Original: |
J:78642 Tarbell KV, et al., CD4(+) T cells from glutamic acid decarboxylase (GAD)65-specific T cell receptor transgenic mice are not diabetogenic and can delay diabetes transfer. J Exp Med. 2002 Aug 19;196(4):481-92 |
| All: |
3 reference(s) |
|